Crosstalk between wnt/β-catenin and NF-κB signaling pathway during inflammation

Frontiers in Immunology

Volumn 7, Issue SEP, 2016, Pages

  Ma, Bin ^a,b   Hottiger, Michael O ^c  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Gene expression; NF B; Signaling pathways; Wnt; catenin

Indexed keywords

BETA CATENIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ADAPTATION; CELL PROLIFERATION; ENDOPLASMIC RETICULUM; HOMEOSTASIS AND REGULATION; HUMAN; IMMUNOPATHOLOGY; INFLAMMATION; KNOWLEDGE; LIVER CELL CULTURE; NONHUMAN; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; WNT SIGNALING PATHWAY;

EID: 84992145999     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2016.00378     Document Type: Review

References (83)

1. Clevers H. Wnt/beta-catenin signaling in development and disease. Cell (2006) 127(3):469-80. doi:10.1016/j.cell.2006.10.018
2. Clevers H, Nusse R. Wnt/beta-catenin signaling and disease. Cell (2012) 149(6):1192-205. doi:10.1016/j.cell.2012.05.012
3. Tak PP, Firestein GS. NF-kappaB: a key role in inflammatory diseases. J Clin Invest (2001) 107(1):7-11. doi:10.1172/JCI11830
4. Li Q, Verma IM. NF-kappaB regulation in the immune system. Nat Rev Immunol (2002) 2(10):725-34. doi:10.1038/nri910
5. Nejak-Bowen K, Kikuchi A, Monga SP. Beta-catenin-NF-kappaB interactions in murine hepatocytes: a complex to die for. Hepatology (2013) 57(2):763-74. doi:10.1002/hep.26042
6. Karin M. NF-kappaB as a critical link between inflammation and cancer. Cold Spring Harb Perspect Biol (2009) 1(5):a000141. doi:10.1101/cshperspect.a000141
7. Ben-Neriah Y, Karin M. Inflammation meets cancer, with NF-kappaB as the matchmaker. Nat Immunol (2011) 12(8):715-23. doi:10.1038/ni.2060
8. Pasparakis M. Regulation of tissue homeostasis by NF-kappaB signalling: implications for inflammatory diseases. Nat Rev Immunol (2009) 9(11):778-88. doi:10.1038/nri2655
9. Anastas JN, Moon RT. WNT signalling pathways as therapeutic targets in cancer. Nat Rev Cancer (2013) 13(1):11-26. doi:10.1038/nrc3419
10. van Amerongen R, Nusse R. Towards an integrated view of Wnt signaling in development. Development (2009) 136(19):3205-14. doi:10.1242/dev.033910
11. Brembeck FH, Rosario M, Birchmeier W. Balancing cell adhesion and Wnt signaling, the key role of beta-catenin. Curr Opin Genet Dev (2006) 16(1):51-9. doi:10.1016/j.gde.2005.12.007
12. Arce L, Yokoyama NN, Waterman ML. Diversity of LEF/TCF action in development and disease. Oncogene (2006) 25(57):7492-504. doi:10.1038/sj.onc.1210056
13. Hoverter NP, Waterman ML. A Wnt-fall for gene regulation: repression. Sci Signal (2008) 1(39):e43. doi:10.1126/scisignal.139pe43
14. Hecht A, Vleminckx K, Stemmler MP, van Roy F, Kemler R. The p300/CBP acetyltransferases function as transcriptional coactivators of beta-catenin in vertebrates. EMBO J (2000) 19(8):1839-50. doi:10.1093/emboj/19.8.1839
15. Idogawa M, Yamada T, Honda K, Sato S, Imai K, Hirohashi S. Poly(ADP-ribose) polymerase-1 is a component of the oncogenic T-cell factor-4/beta-catenin complex. Gastroenterology (2005) 128(7):1919-36. doi:10.1053/j.gastro.2005.03.007
16. Chiurillo MA. Role of the Wnt/beta-catenin pathway in gastric cancer: an in-depth literature review. World J Exp Med (2015) 5(2):84-102. doi:10.5493/wjem.v5.i2.84
17. Stewart DJ. Wnt signaling pathway in non-small cell lung cancer. J Natl Cancer Inst (2014) 106(1):djt356. doi:10.1093/jnci/djt356
18. Deng J, Miller SA, Wang HY, Xia W, Wen Y, Zhou BP, et al. Beta-catenin interacts with and inhibits NF-kappa B in human colon and breast cancer. Cancer Cell (2002) 2(4):323-34. doi:10.1016/S1535-6108(02)00154-X
19. Jian H, Shen X, Liu I, Semenov M, He X, Wang XF. Smad3-dependent nuclear translocation of beta-catenin is required for TGF-beta1-induced proliferation of bone marrow-derived adult human mesenchymal stem cells. Genes Dev (2006) 20(6):666-74. doi:10.1101/gad.1388806
20. Rodilla V, Villanueva A, Obrador-Hevia A, Robert-Moreno A, Fernandez-Majada V, Grilli A, et al. Jagged1 is the pathological link between Wnt and Notch pathways in colorectal cancer. Proc Natl Acad Sci U S A (2009) 106(15):6315-20. doi:10.1073/pnas.0813221106
21. Essers MA, de Vries-Smits LM, Barker N, Polderman PE, Burgering BM, Korswagen HC. Functional interaction between beta-catenin and FOXO in oxidative stress signaling. Science (2005) 308(5725):1181-4. doi:10.1126/science.1109083
22. Mazumdar J, O'Brien WT, Johnson RS, LaManna JC, Chavez JC, Klein PS, et al. O2 regulates stem cells through Wnt/beta-catenin signalling. Nat Cell Biol (2010) 12(10):1007-13. doi:10.1038/ncb2102
23. Mitchell S, Vargas J, Hoffmann A. Signaling via the NFkappaB system. Wiley Interdiscip Rev Syst Biol Med (2016) 8(3):227-41. doi:10.1002/wsbm.1331
24. Kingeter LM, Paul S, Maynard SK, Cartwright NG, Schaefer BC. Cutting edge: TCR ligation triggers digital activation of NF-kappaB. J Immunol (2010) 185(8):4520-4. doi:10.4049/jimmunol.1001051
25. Gerritsen ME, Williams AJ, Neish AS, Moore S, Shi Y, Collins T. CREB-binding protein/p300 are transcriptional coactivators of p65. Proc Natl Acad Sci U S A (1997) 94(7):2927-32. doi:10.1073/pnas.94.7.2927
26. Hassa PO, Buerki C, Lombardi C, Imhof R, Hottiger MO. Transcriptional coactivation of nuclear factor-kappaB-dependent gene expression by p300 is regulated by poly(ADP)-ribose polymerase-1. J Biol Chem (2003) 278(46):45145-53. doi:10.1074/jbc.M307957200
27. Du Q, Zhang X, Cardinal J, Cao Z, Guo Z, Shao L, et al. Wnt/beta-catenin signaling regulates cytokine-induced human inducible nitric oxide synthase expression by inhibiting nuclear factor-kappaB activation in cancer cells. Cancer Res (2009) 69(9):3764-71. doi:10.1158/0008-5472.CAN-09-0014
28. Moreau M, Mourah S, Dosquet C. Beta-catenin and NF-kappaB cooperate to regulate the uPA/uPAR system in cancer cells. Int J Cancer (2011) 128(6):1280-92. doi:10.1002/ijc.25455
29. Rodriguez-Pinilla M, Rodriguez-Peralto JL, Hitt R, Sanchez JJ, Sanchez-Verde L, Alameda F, et al. Beta-catenin, Nf-kappaB and FAS protein expression are independent events in head and neck cancer: study of their association with clinical parameters. Cancer Lett (2005) 230(1):141-8. doi:10.1016/j.canlet.2004.12.045
30. Liu J, Liao Y, Ma K, Wang Y, Zhang G, Yang R, et al. PI3K is required for the physical interaction and functional inhibition of NF-kappaB by beta-catenin in colorectal cancer cells. Biochem Biophys Res Commun (2013) 434(4):760-6. doi:10.1016/j.bbrc.2013.03.135
31. Ma B, van Blitterswijk CA, Karperien M. A Wnt/beta-catenin negative feedback loop inhibits interleukin-1-induced matrix metalloproteinase expression in human articular chondrocytes. Arthritis Rheum (2012) 64(8):2589-600. doi:10.1002/art.34425
32. Ma B, Fey M, Hottiger MO. WNT/beta-catenin signaling inhibits CBP-mediated RelA acetylation and expression of proinflammatory NF-kappaB target genes. J Cell Sci (2015) 128(14):2430-6. doi:10.1242/jcs.168542
33. Sun J, Hobert ME, Duan Y, Rao AS, He TC, Chang EB, et al. Crosstalk between NF-kappaB and beta-catenin pathways in bacterial-colonized intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol (2005) 289(1):G129-37. doi:10.1152/ajpgi.00515.2004
34. Duan Y, Liao AP, Kuppireddi S, Ye Z, Ciancio MJ, Sun J. Beta-catenin activity negatively regulates bacteria-induced inflammation. Lab Invest (2007) 87(6):613-24. doi:10.1038/labinvest.3700545
35. Die L, Yan P, Jun Jiang Z, Min Hua T, Cai W, Xing L. Glycogen synthase kinase-3 beta inhibitor suppresses Porphyromonas gingivalis lipopolysaccharide-induced CD40 expression by inhibiting nuclear factor-kappa B activation in mouse osteoblasts. Mol Immunol (2012) 52(1):38-49. doi:10.1016/j.molimm.2012.04.005
36. Jiang R, Chen D, Hou J, Tan Z, Wang Y, Huang X, et al. Survival and inflammation promotion effect of PTPRO in fulminant hepatitis is associated with NF-kappaB activation. J Immunol (2014) 193(10):5161-70. doi:10.4049/jimmunol.1303354
37. Kim SJ, Lim JY, Lee JN, Choe SK, Kim YI, Song SR, et al. Activation of beta-catenin by inhibitors of glycogen synthase kinase-3 ameliorates cisplatin-induced cytotoxicity and pro-inflammatory cytokine expression in HEI-OC1 cells. Toxicology (2014) 320:74-82. doi:10.1016/j.tox.2014.01.013
38. Hao HP, Wen LB, Li JR, Wang Y, Ni B, Wang R, et al. LiCl inhibits PRRSV infection by enhancing Wnt/beta-catenin pathway and suppressing inflammatory responses. Antiviral Res (2015) 117:99-109. doi:10.1016/j.antiviral.2015.02.010
39. Kim JH, Kim B, Cai L, Choi HJ, Ohgi KA, Tran C, et al. Transcriptional regulation of a metastasis suppressor gene by Tip60 and beta-catenin complexes. Nature (2005) 434(7035):921-6. doi:10.1038/nature03452
40. Ke B, Shen XD, Kamo N, Ji H, Yue S, Gao F, et al. Beta-catenin regulates innate and adaptive immunity in mouse liver ischemia-reperfusion injury. Hepatology (2013) 57(3):1203-14. doi:10.1002/hep.26100
41. Manicassamy S, Reizis B, Ravindran R, Nakaya H, Salazar-Gonzalez RM, Wang YC, et al. Activation of beta-catenin in dendritic cells regulates immunity versus tolerance in the intestine. Science (2010) 329(5993):849-53. doi:10.1126/science.1188510
42. Winston JT, Strack P, Beer-Romero P, Chu CY, Elledge SJ, Harper JW. The SCFbeta-TRCP-ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in IkappaBalpha and beta-catenin and stimulates IkappaBalpha ubiquitination in vitro. Genes Dev (1999) 13(3):270-83. doi:10.1101/gad.13.3.270
43. Spiegelman VS, Slaga TJ, Pagano M, Minamoto T, Ronai Z, Fuchs SY. Wnt/beta-catenin signaling induces the expression and activity of betaTrCP ubiquitin ligase receptor. Mol Cell (2000) 5(5):877-82. doi:10.1016/S1097-2765(00)80327-5
44. Wang X, Adhikari N, Li Q, Guan Z, Hall JL. The role of [beta]-transducin repeat-containing protein ([beta]-TrCP) in the regulation of NF-[kappa]B in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol (2004) 24(1):85-90. doi:10.1161/01.ATV.0000104012.40720.c4
45. Noubissi FK, Elcheva I, Bhatia N, Shakoori A, Ougolkov A, Liu J, et al. CRD-BP mediates stabilization of betaTrCP1 and c-myc mRNA in response to beta-catenin signalling. Nature (2006) 441(7095):898-901. doi:10.1038/nature04839
46. Ougolkov A, Zhang B, Yamashita K, Bilim V, Mai M, Fuchs SY, et al. Associations among beta-TrCP, an E3 ubiquitin ligase receptor, beta-catenin, and NF-kappaB in colorectal cancer. J Natl Cancer Inst (2004) 96(15):1161-70. doi:10.1093/jnci/djh219
47. Jia D, Yang W, Li L, Liu H, Tan Y, Ooi S, et al. Beta-catenin and NF-kappaB co-activation triggered by TLR3 stimulation facilitates stem cell-like phenotypes in breast cancer. Cell Death Differ (2015) 22(2):298-310. doi:10.1038/cdd.2014.145
48. Bognar MK, Vincendeau M, Erdmann T, Seeholzer T, Grau M, Linnemann JR, et al. Oncogenic CARMA1 couples NF-kappaB and beta-catenin signaling in diffuse large B-cell lymphomas. Oncogene (2016) 35(32):4269-81. doi:10.1038/onc.2015.493
49. Choi YS, Hur J, Jeong S. Beta-catenin binds to the downstream region and regulates the expression C-reactive protein gene. Nucleic Acids Res (2007) 35(16):5511-9. doi:10.1093/nar/gkm547
50. Yun K, So JS, Jash A, Im SH. Lymphoid enhancer binding factor 1 regulates transcription through gene looping. J Immunol (2009) 183(8):5129-37. doi:10.4049/jimmunol.0802744
51. Anson M, Crain-Denoyelle AM, Baud V, Chereau F, Gougelet A, Terris B, et al. Oncogenic beta-catenin triggers an inflammatory response that determines the aggressiveness of hepatocellular carcinoma in mice. J Clin Invest (2012) 122(2):586-99. doi:10.1172/JCI43937
52. Phelps RA, Broadbent TJ, Stafforini DM, Jones DA. New perspectives on APC control of cell fate and proliferation in colorectal cancer. Cell Cycle (2009) 8(16):2549-56. doi:10.4161/cc.8.16.9278
53. Kuphal S, Poser I, Jobin C, Hellerbrand C, Bosserhoff AK. Loss of E-cadherin leads to upregulation of NFkappaB activity in malignant melanoma. Oncogene (2004) 23(52):8509-19. doi:10.1038/sj.onc.1207831
54. Bandino A, Compagnone A, Bravoco V, Cravanzola C, Lomartire A, Rossetto C, et al. Beta-catenin triggers nuclear factor kappaB-dependent up-regulation of hepatocyte inducible nitric oxide synthase. Int J Biochem Cell Biol (2008) 40(9):1861-71. doi:10.1016/j.biocel.2008.01.029
55. Solanas G, Porta-de-la-Riva M, Agusti C, Casagolda D, Sanchez-Aguilera F, Larriba MJ, et al. E-cadherin controls beta-catenin and NF-kappaB transcriptional activity in mesenchymal gene expression. J Cell Sci (2008) 121(Pt 13):2224-34. doi:10.1242/jcs.021667
56. Zhao W, Sun Z, Wang S, Li Z, Zheng L. Wnt1 participates in inflammation induced by lipopolysaccharide through upregulating scavenger receptor A and NF-kB. Inflammation (2015) 38(4):1700-6. doi:10.1007/s10753-015-0147-8
57. Schon S, Flierman I, Ofner A, Stahringer A, Holdt LM, Kolligs FT, et al. Beta-catenin regulates NF-kappaB activity via TNFRSF19 in colorectal cancer cells. Int J Cancer (2014) 135(8):1800-11. doi:10.1002/ijc.28839
58. Jang J, Ha JH, Chung SI, Yoon Y. Beta-catenin regulates NF-kappaB activity and inflammatory cytokine expression in bronchial epithelial cells treated with lipopolysaccharide. Int J Mol Med (2014) 34(2):632-8. doi:10.3892/ijmm.2014.1807
59. Ma B, Zhong L, van Blitterswijk CA, Post JN, Karperien M. T cell factor 4 is a pro-catabolic and apoptotic factor in human articular chondrocytes by potentiating nuclear factor kappaB signaling. J Biol Chem (2013) 288(24):17552-8. doi:10.1074/jbc.M113.453985
60. Cummins EP, Berra E, Comerford KM, Ginouves A, Fitzgerald KT, Seeballuck F, et al. Prolyl hydroxylase-1 negatively regulates IkappaB kinase-beta, giving insight into hypoxia-induced NFkappaB activity. Proc Natl Acad Sci U S A (2006) 103(48):18154-9. doi:10.1073/pnas.0602235103
61. Scholz CC, Cavadas MA, Tambuwala MM, Hams E, Rodriguez J, von Kriegsheim A, et al. Regulation of IL-1beta-induced NF-kappaB by hydroxylases links key hypoxic and inflammatory signaling pathways. Proc Natl Acad Sci U S A (2013) 110(46):18490-5. doi:10.1073/pnas.1309718110
62. Saegusa M, Hashimura M, Kuwata T, Hamano M, Okayasu I. Crosstalk between NF-kappaB/p65 and beta-catenin/TCF4/p300 signalling pathways through alterations in GSK-3beta expression during trans-differentiation of endometrial carcinoma cells. J Pathol (2007) 213(1):35-45. doi:10.1002/path.2198
63. Buss H, Dorrie A, Schmitz ML, Frank R, Livingstone M, Resch K, et al. Phosphorylation of serine 468 by GSK-3beta negatively regulates basal p65 NF-kappaB activity. J Biol Chem (2004) 279(48):49571-4. doi:10.1074/jbc.C400442200
64. Hoeflich KP, Luo J, Rubie EA, Tsao MS, Jin O, Woodgett JR. Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation. Nature (2000) 406(6791):86-90. doi:10.1038/35017574
65. Martin M, Rehani K, Jope RS, Michalek SM. Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3. Nat Immunol (2005) 6(8):777-84. doi:10.1038/ni1221
66. Kotliarova S, Pastorino S, Kovell LC, Kotliarov Y, Song H, Zhang W, et al. Glycogen synthase kinase-3 inhibition induces glioma cell death through c-MYC, nuclear factor-kappaB, and glucose regulation. Cancer Res (2008) 68(16):6643-51. doi:10.1158/0008-5472.CAN-08-0850
67. Hofmann C, Dunger N, Scholmerich J, Falk W, Obermeier F. Glycogen synthase kinase 3-beta: a master regulator of toll-like receptor-mediated chronic intestinal inflammation. Inflamm Bowel Dis (2010) 16(11):1850-8. doi:10.1002/ibd.21294
68. Thyssen G, Li TH, Lehmann L, Zhuo M, Sharma M, Sun Z. LZTS2 is a novel beta-catenin-interacting protein and regulates the nuclear export of beta-catenin. Mol Cell Biol (2006) 26(23):8857-67. doi:10.1128/MCB.01031-06
69. Cho HH, Song JS, Yu JM, Yu SS, Choi SJ, Kim DH, et al. Differential effect of NF-kappaB activity on beta-catenin/Tcf pathway in various cancer cells. FEBS Lett (2008) 582(5):616-22. doi:10.1016/j.febslet.2008.01.029
70. Chang J, Liu F, Lee M, Wu B, Ting K, Zara JN, et al. NF-kappaB inhibits osteogenic differentiation of mesenchymal stem cells by promoting beta-catenin degradation. Proc Natl Acad Sci U S A (2013) 110(23):9469-74. doi:10.1073/pnas.1300532110
71. Gwak J, Park S, Cho M, Song T, Cha SH, Kim DE, et al. Polysiphonia japonica extract suppresses the Wnt/beta-catenin pathway in colon cancer cells by activation of NF-kappaB. Int J Mol Med (2006) 17(6):1005-10. doi:10.3892/ijmm.17.6.1005
72. Lamberti C, Lin KM, Yamamoto Y, Verma U, Verma IM, Byers S, et al. Regulation of beta-catenin function by the IkappaB kinases. J Biol Chem (2001) 276(45):42276-86. doi:10.1074/jbc.M104227200
73. Albanese C, Wu K, D'Amico M, Jarrett C, Joyce D, Hughes J, et al. IKKalpha regulates mitogenic signaling through transcriptional induction of cyclin D1 via Tcf. Mol Biol Cell (2003) 14(2):585-99. doi:10.1091/mbc.02-06-0101
74. Carayol N, Wang CY. IKKalpha stabilizes cytosolic beta-catenin by inhibiting both canonical and non-canonical degradation pathways. Cell Signal (2006) 18(11):1941-6. doi:10.1016/j.cellsig.2006.02.014
75. Schwitalla S, Fingerle AA, Cammareri P, Nebelsiek T, Goktuna SI, Ziegler PK, et al. Intestinal tumorigenesis initiated by dedifferentiation and acquisition of stem-cell-like properties. Cell (2013) 152(1-2):25-38. doi:10.1016/j.cell.2012.12.012
76. Li D, Beisswenger C, Herr C, Hellberg J, Han G, Zakharkina T, et al. Myeloid cell RelA/p65 promotes lung cancer proliferation through Wnt/beta-catenin signaling in murine and human tumor cells. Oncogene (2014) 33(10):1239-48. doi:10.1038/onc.2013.75
77. Yun K, Choi YD, Nam JH, Park Z, Im SH. NF-kappaB regulates Lef1 gene expression in chondrocytes. Biochem Biophys Res Commun (2007) 357(3):589-95. doi:10.1016/j.bbrc.2007.03.170
78. Hyun Hwa C, Hye Joon J, Ji Sun S, Yong Chan B, Jin Sup J. Crossregulation of beta-catenin/Tcf pathway by NF-kappaB is mediated by lzts2 in human adipose tissue-derived mesenchymal stem cells. Biochim Biophys Acta (2008) 1783(3):419-28. doi:10.1016/j.bbamcr.2007.08.005
79. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell (2011) 144(5):646-74. doi:10.1016/j.cell.2011.02.013
80. Oguma K, Oshima H, Aoki M, Uchio R, Naka K, Nakamura S, et al. Activated macrophages promote Wnt signalling through tumour necrosis factor-alpha in gastric tumour cells. EMBO J (2008) 27(12):1671-81. doi:10.1038/emboj.2008.105
81. Zhang Y, Tomann P, Andl T, Gallant NM, Huelsken J, Jerchow B, et al. Reciprocal requirements for EDA/EDAR/NF-kappaB and Wnt/beta-catenin signaling pathways in hair follicle induction. Dev Cell (2009) 17(1):49-61. doi:10.1016/j.devcel.2009.05.011
82. Fliniaux I, Mikkola ML, Lefebvre S, Thesleff I. Identification of dkk4 as a target of Eda-A1/Edar pathway reveals an unexpected role of ectodysplasin as inhibitor of Wnt signalling in ectodermal placodes. Dev Biol (2008) 320(1):60-71. doi:10.1016/j.ydbio.2008.04.023
83. Wen F, Liu Y, Wang W, Li M, Guo F, Sang Y, et al. Adenomatous polyposis coli genotype-dependent toll-like receptor 4 activity in colon cancer. Oncotarget (2016) 7(7):7761-72. doi:10.18632/oncotarget.6844